Zuellig Pharma

ABBVIE SDN BHD

Featured products of Abbvie
upadacitinib
Packing/Price
28's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Other Dermatologicals
ATC Classification
L04AF03 - upadacitinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used as immunosuppressants.
risankizumab
Packing/Price
1's
MIMS Class
Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations
ATC Classification
L04AC18 - risankizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
Distributed by Zuellig Pharma
upadacitinib
Packing/Price
28's
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Other Dermatologicals
ATC Classification
L04AF03 - upadacitinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used as immunosuppressants.
risankizumab
Packing/Price
1's
MIMS Class
Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations
ATC Classification
L04AC18 - risankizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in